Guro L. Goll, MD, PhD

Diakonhjemmet Hospital
Oslo, Norway

Clinical specialist in rheumatology also working with clinical research. Educated at University of Oslo. 2001 PhD in immunology.

Disclosure information not submitted.

Presentation(s):

• 0774: HLA-DQ2 Is Associated with Anti-drug Antibody Formation to Infliximab Across Immune-mediated Inflammatory Diseases

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 0774: HLA-DQ2 Is Associated with Anti-drug Antibody Formation to Infliximab Across Immune-mediated Inflammatory Diseases

  Monday, November 14, 2022
  1:00 PM – 1:05 PM Eastern Time